Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cancer chemotherapy

M H Cullen

    The Practitioner
    |October 1, 1976
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Management of febrile neutropenia: ESMO Clinical Practice Guidelines.

    Annals of oncology : official journal of the European Society for Medical Oncology·2010
    Same author

    Initial dose intensity has limited impact on the outcome of ABVD chemotherapy for advanced Hodgkin lymphoma (HL): data from UKLG LY09 (ISRCTN97144519).

    Annals of oncology : official journal of the European Society for Medical Oncology·2009
    Same author

    Management of febrile neutropenia: ESMO clinical recommendations.

    Annals of oncology : official journal of the European Society for Medical Oncology·2009
    Same author

    A phase II clinical trial of gemcitabine and split dose cisplatin in advanced non-small cell lung cancer in an outpatient setting.

    Oncology reports·2008
    Same author

    A randomized phase III trial comparing standard and high-dose pemetrexed as second-line treatment in patients with locally advanced or metastatic non-small-cell lung cancer.

    Annals of oncology : official journal of the European Society for Medical Oncology·2008
    Same author

    A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial.

    British journal of cancer·2005
    Same journal

    Improving pain control in diabetic neuropathy.

    The Practitioner·2017
    Same journal

    Tailor management to the patient with fibroids.

    The Practitioner·2017
    Same journal

    Preventing stroke and assessing risk in women.

    The Practitioner·2017
    Same journal

    Depression in adults linked to maltreatment in childhood.

    The Practitioner·2017
    Same journal

    Early referral improves long-term outcomes in rheumatoid arthritis.

    The Practitioner·2017
    Same journal

    Diagnosing and managing mild cognitive impairment.

    The Practitioner·2017
    See all related articles